US EditionPublished • loading... • Updated
Carlsmed Poised for Positive Growth Trajectory
Summary by San Diego Business Journal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Carlsmed Poised for Positive Growth Trajectory
CARLSBAD – After a big year in 2025 that included a $100 million IPO, Carlsmed (Nasdaq: CARL) is positioned to have an even bigger 2026 with full commercial launches of new surgical procedures for its AI-powered personalized spine technology, including bilateral lumbar interbody fusion and cervical plating. “Now that we’re on the other side of […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
